Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study

Neurology

Volumn 79, Issue 18, 2012, Pages 1846-1852

  Shao, Huibo ^a   Breitner, John C S ^b   Whitmer, Rachel A ^c   Wang, Junmin ^d   Hayden, Kathleen ^e   Wengreen, Heidi ^f   Corcoran, Chris ^f   Tschanz, Jo Ann ^f   Norton, Maria ^f   Munger, Ron ^f   Welsh Bohmer, Kathleen ^e   Zandi, Peter P ^g  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c DIVISION OF RESEARCH   (United States)

^d University of Memphis   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UTAH STATE UNIVERSITY   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; HORMONAL THERAPY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENOPAUSE; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT DURATION;

EID: 84871328175     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318271f823     Document Type: Article

References (29)

1. Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997; 48:S27-S35.
2. Henderson VW. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 2006;138:1031-1039.
3. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
4. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
5. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288: 2123-2129.
6. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.
7. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291:2947-2958.
8. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288: 2170-2172.
9. Breitner JC, Wyse BW, Anthony JC, et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 1999;53: 321-331.
10. Miech RA, Breitner JC, Zandi PP, et al. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology 2002;58:209-218.
11. Richards B, Skoletsky J, Shuber AP, et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 1993;2: 159-163.
12. Saunders AM, Roses AD. Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke 1993;24:1416-1417.
13. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
14. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 1994;24:145-153.
15. Silverman JM, Breitner JC, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry 1986;143:1279-1282.
16. Tschanz JT, Welsh-Bohmer KA, Skoog I, et al. Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology 2000;54: 1290-1296.
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
18. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
19. Tatemichi TK, Sacktor N, Mayeux R. Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York: Raven Press; 1994:123-166.
20. Hayden KM, Khachaturian AS, Tschanz JT, et al. Characteristics of a two-stage screen for incident dementia. J Clin Epidemiol 2003;56:1038-1045.
21. Fearing MA, Bigler ED, Norton M, et al. Autopsyconfirmed Alzheimer's disease versus clinically diagnosed Alzheimer's disease in the Cache County Study on Memory and Aging: a comparison of quantitative MRI and neuropsychological findings. J Clin Exp Neuropsychol 2007; 29:553-560.
22. Wengreen HJ, Nelson C, Munger R, Corcoran C. DASH diet adherence scores and cognitive decline and dementia among aging men and women: Cache County Study of Memory Health and Aging. Alzheimers Dement 2009;5: 128.
23. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-695.
24. Hogervorst E, Williams J, Budge M, et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a metaanalysis. Neuroscience 2000;101:485-512.
25. Henderson VW, Benke KS, Green RC, et al. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005; 76:103-105.
26. Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011;69:163-169.
27. Khachaturian AS, Gallo JJ, Breitner JC. Performance characteristics of a two-stage dementia screen in a population sample. J Clin Epidemiol 2000;53:531-540.
28. Plassman BL, Khachaturian AS, Townsend JJ, et al.Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples. Alzheimers Dement 2006;2:2-11.
29. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause 2010;17:242-255.